3.19
price up icon0.00%   0.00
after-market After Hours: 3.19
loading
Black Diamond Therapeutics Inc stock is traded at $3.19, with a volume of 203.65K. It is up +0.00% in the last 24 hours and up +40.53% over the past month. Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
See More
Previous Close:
$3.19
Open:
$3.165
24h Volume:
203.65K
Relative Volume:
0.18
Market Cap:
$181.39M
Revenue:
-
Net Income/Loss:
$-82.44M
P/E Ratio:
-1.6968
EPS:
-1.88
Net Cash Flow:
$-66.75M
1W Performance:
+4.93%
1M Performance:
+40.53%
6M Performance:
+27.60%
1Y Performance:
-48.63%
1-Day Range:
Value
$3.16
$3.23
1-Week Range:
Value
$3.02
$3.315
52-Week Range:
Value
$1.195
$6.75

Black Diamond Therapeutics Inc Stock (BDTX) Company Profile

Name
Name
Black Diamond Therapeutics Inc
Name
Phone
617-417-5868
Name
Address
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
Name
Employee
54
Name
Twitter
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
BDTX's Discussions on Twitter

Compare BDTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
BDTX
Black Diamond Therapeutics Inc
3.19 181.39M 0 -82.44M -66.75M -1.88
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-01-25 Resumed Raymond James Outperform
Jul-31-24 Initiated Raymond James Outperform
Jul-14-23 Initiated Piper Sandler Overweight
Jun-30-23 Upgrade Stifel Hold → Buy
Jun-28-23 Upgrade H.C. Wainwright Neutral → Buy
Jun-27-23 Upgrade Wedbush Neutral → Outperform
Mar-29-22 Downgrade Wedbush Outperform → Neutral
Mar-22-22 Downgrade H.C. Wainwright Buy → Neutral
Sep-30-21 Initiated Stifel Hold
Jan-07-21 Initiated Wedbush Outperform
Nov-24-20 Initiated Berenberg Buy
May-04-20 Initiated H.C. Wainwright Buy
Feb-24-20 Initiated Canaccord Genuity Buy
Feb-24-20 Initiated Cowen Outperform
Feb-24-20 Initiated JP Morgan Overweight
Feb-24-20 Initiated Jefferies Buy
View All

Black Diamond Therapeutics Inc Stock (BDTX) Latest News

pulisher
04:36 AM

What analysts say about Black Diamond Therapeutics Inc. stockGame-changing capital returns - Autocar Professional

04:36 AM
pulisher
Jul 22, 2025

Is Black Diamond Therapeutics Inc. a good long term investmentUnstoppable profit momentum - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Black Diamond Therapeutics Inc. Stock Analysis and ForecastTriple-digit profit margins - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Black Diamond Therapeutics Inc. stock attracts strong analyst attentionFree Stock Market Forecasting Tools - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

What drives Black Diamond Therapeutics Inc. stock priceMarket-leading capital gains - Autocar Professional

Jul 21, 2025
pulisher
Jul 17, 2025

Black Diamond Therapeutics, Inc. (BDTX) Rated Outperform as Lead Drug Shows Promise - MSN

Jul 17, 2025
pulisher
Jul 16, 2025

why edgewise therapeutics inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Black Diamond Therapeutics discloses EGFR inhibitors for cancer - BioWorld MedTech

Jul 16, 2025
pulisher
Jul 15, 2025

How Black Diamond Therapeutics Inc. stock performs during market volatilityMarket Beating Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Black Diamond Therapeutics Inc. stock price move sharplyGroup Only Stock Signals - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Consensus Rating of “Buy” from Analysts - Defense World

Jul 11, 2025
pulisher
Jul 11, 2025

10 Best Get Rich Quick Stocks to Buy Now - Insider Monkey

Jul 11, 2025
pulisher
Jun 30, 2025

Black Diamond Therapeutics, Inc.(NasdaqGS: BDTX) dropped from Russell 2500 Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) dropped from Russell 2500 Value Index - MarketScreener

Jun 29, 2025
pulisher
Jun 16, 2025

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Holdings Boosted by Bank of America Corp DE - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Average Rating of “Buy” from Analysts - Defense World

Jun 16, 2025
pulisher
Jun 14, 2025

Black Diamond Therapeutics (NASDAQ:BDTX) Upgraded at Wall Street Zen - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Black Diamond’s 2025 Annual Stockholders Meeting Highlights - TipRanks

Jun 12, 2025
pulisher
Jun 10, 2025

Black Diamond Therapeutics: Targeted Approach And Early Efficacy Signals Create Potential For Significant Upside - Seeking Alpha

Jun 10, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Grows Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Buys 72,688 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Black Diamond Therapeutics (NASDAQ:BDTX) Downgraded to Hold Rating by Wall Street Zen - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Pre-market Movers: BDTX, CRGX, PASG, RGC... - RTTNews

Jun 06, 2025
pulisher
Jun 06, 2025

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Nuveen Asset Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Purchased by Millennium Management LLC - Defense World

Jun 05, 2025
pulisher
May 30, 2025

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Northern Trust Corp - Defense World

May 30, 2025
pulisher
May 29, 2025

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference - GlobeNewswire

May 29, 2025
pulisher
May 29, 2025

17,317 Shares in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Bought by D. E. Shaw & Co. Inc. - Defense World

May 29, 2025
pulisher
May 26, 2025

Black Diamond Therapeutics (NASDAQ:BDTX) & Fresh Tracks Therapeutics (NASDAQ:FRTX) Critical Comparison - Defense World

May 26, 2025
pulisher
May 25, 2025

Brokerages Set Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Price Target at $14.60 - Defense World

May 25, 2025
pulisher
May 24, 2025

Black Diamond Therapeutics (NASDAQ:BDTX) Raised to Buy at Wall Street Zen - Defense World

May 24, 2025

Black Diamond Therapeutics Inc Stock (BDTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Cap:     |  Volume (24h):